Billionaire Joseph Edelman’s Top 10 Long-Term Stock Picks

Page 8 of 10

3. Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)

Number of Hedge Fund Holders: 30   

Perceptive Advisors’ Stake: $19.1 million

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is the global leader in innovating, developing and delivering Tumor Infiltrating Lymphocyte (TIL) therapies for patients with cancer. As per the report of the third quarter revenue of 2024, the company recognized total revenue of $58.6 million from sales of Amtagvi and Proleukin. Moreover, the company’s state-of-the-art manufacturing facility in Philadelphia also ensures efficiency in the production of TIL therapies. This is great as it reduces dependency on third manufacturing and enhances operational control.

Page 8 of 10